This is a StreetInsider.com Premium Only Page

(ROIV) – Business Wire

Oct 3, 2023 07:37 AM Lokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific

Apr 4, 2023 07:37 AM Lokavant Emerges from Roivant Sciences with Multiple Industry Partnerships to Accelerate Impact on Clinical Research

Apr 4, 2023 07:37 AM Lokavant Hires Experienced Leaders to Accelerate Growth Trajectory

Mar 15, 2023 07:45 AM Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old

Jun 28, 2022 06:00 AM Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus

May 24, 2022 06:00 AM FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years

Jan 18, 2022 08:00 AM TandemAI Announces Expansion of Senior Leadership Team

Jan 4, 2022 08:30 AM Full-Life Technologies Announces Senior Executive Team Appointments

Oct 29, 2021 07:52 AM Roivant Discovery Announces 2021 Open Science Fellows